Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
18.15
-1.31 (-6.73%)
At close: Sep 10, 2025, 4:00 PM
18.30
+0.15 (0.83%)
After-hours: Sep 10, 2025, 7:48 PM EDT
Schrödinger Revenue
Schrödinger had revenue of $54.76M in the quarter ending June 30, 2025, with 15.69% growth. This brings the company's revenue in the last twelve months to $237.92M, up 18.59% year-over-year. In the year 2024, Schrödinger had annual revenue of $207.54M, down -4.21%.
Revenue (ttm)
$237.92M
Revenue Growth
+18.59%
P/S Ratio
5.57
Revenue / Employee
$267,022
Employees
891
Market Cap
1.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SDGR News
- 2 days ago - Schrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 14 days ago - Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
- 26 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - Schrödinger Announces Discontinuation of SGR-2921 Program - Business Wire
- 5 weeks ago - Schrödinger, Inc. (SDGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Schrödinger Reports Second Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6 - Business Wire
- 7 weeks ago - Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - GlobeNewsWire